Alterity Therapeutics (ATHE) Shares Outstanding (Diluted Average) (2016 - 2025)
Alterity Therapeutics has reported Shares Outstanding (Diluted Average) over the past 3 years, most recently at $1.1 million for Q4 2018.
Alterity Therapeutics has reported Shares Outstanding (Diluted Average) over the past 3 years, most recently at $1.1 million for Q4 2018.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month